Allergan denied dismissal of patent challenges for dry eye medication Restasis

Allergan likely expected to have the patent challenges dismissed under a deal with a New York State American Indian tribe.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.